Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 13;18(6):1260.
doi: 10.3390/ijms18061260.

The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis

Megan Yu  1 , Sheng-Feng Tsai  2 , Yu-Min Kuo  3   4
Affiliations
Review

The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis

Megan Yu et al. Int J Mol Sci. .

Abstract

Although many cardiovascular (CVD) medications, such as antithrombotics, statins, and antihypertensives, have been identified to treat atherosclerosis, at most, many of these therapeutic agents only delay its progression. A growing body of evidence suggests physical exercise could be implemented as a non-pharmacologic treatment due to its pro-metabolic, multisystemic, and anti-inflammatory benefits. Specifically, it has been discovered that certain anti-inflammatory peptides, metabolites, and RNA species (collectively termed "exerkines") are released in response to exercise that could facilitate these benefits and could serve as potential therapeutic targets for atherosclerosis. However, much of the relationship between exercise and these exerkines remains unanswered, and there are several challenges in the discovery and validation of these exerkines. This review primarily highlights major anti-inflammatory exerkines that could serve as potential therapeutic targets for atherosclerosis. To provide some context and comparison for the therapeutic potential of exerkines, the anti-inflammatory, multisystemic benefits of exercise, the basic mechanisms of atherosclerosis, and the limited efficacies of current anti-inflammatory therapeutics for atherosclerosis are briefly summarized. Finally, key challenges and future directions for exploiting these exerkines in the treatment of atherosclerosis are discussed.

Keywords: atherosclerosis; exerkine; physical exercise.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. WHO . World Health Statistics 2016: Monitoring Health for the SDGs Sustainable Development Goals. World Health Organization; Geneva, Switzerland: 2016.
    1. American Heart Association Heart Disease, Stroke and Research Statistics At-a-Glance. [(accessed on 10 June 2017)]; Available online: https://www.heart.org/idc/groups/ahamah-public/@wcm/@sop/@smd/documents/....
    1. Lusis A.J. Atherosclerosis. Nature. 2000;407:233–241. doi: 10.1038/35025203. - DOI - PMC - PubMed
    1. Bentzon J.F., Otsuka F., Virmani R., Falk E. Mechanisms of plaque formation and rupture. Circ. Res. 2014;114:1852–1866. doi: 10.1161/CIRCRESAHA.114.302721. - DOI - PubMed
    1. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., Watson A.D., Lusis A.J. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995;91:2488–2496. doi: 10.1161/01.CIR.91.9.2488. - DOI - PubMed

LinkOut - more resources